Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (8): 103-108.doi: 10.6040/j.issn.1671-7554.0.2022.0205

Previous Articles     Next Articles

A case of primary ciliary dyskinesia caused by a novel DNAH5 gene mutation

WANG Lumin, ZHOU Shiying, HUANG Qikun, LIU Yanli   

  1. Department of Pediatric, Qilu Hospital(Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao 266035, Shandong, China
  • Published:2022-07-27

Abstract: Objective To explore the clinical characteristics, diagnosis and treatment of primary ciliary dyskinesia(PCD)caused by DNAH5 gene mutation. Methods The clinical data of a child with PCD admitted to our hospital were retrospectively analyzed, including the main symptoms, laboratory examination results, imaging findings, gene detection results, transmission electron microscopy(TEM)results and the diagnosis and treatment progress. Results The child had respiratory distress in the neonatal period; repeated cough, sputum, bronchiectasis and chronic sinusitis in infancy. TEM of bronchial mucosa revealed no cilium and the whole exon sequencing indicated a pathogenic compound heterozygous mutation of DNAH5 gene. The diagnosis of PCD was confirmed. Anti-infection and airway clearance therapy were given in the acute stage, and regular follow-up was performed. Conclusion PCD has a variety of clinical manifestations and lacks a single specific diagnosis test. For suspicious patients, a comprehensive analysis of high-speed video microscopy, immunofluorescence microscopy, TEM and gene detection is required to confirm the diagnosis. Currently, there is no cure for PCD, the aim of treatment is to delay the progression of the disease.

Key words: Primary ciliary dyskinesia, Bronchiectasis, Chronic sinusitis, Transmission electron microscopy, Gene detection

CLC Number: 

  • R725
[1] Lucas JS, Davis SD, Omran H, et al. Primary ciliary dyskinesia in the genomics age[J]. Lancet Respir Med, 2020, 8(2): 202-216.
[2] Hannah WB, Seifert BA, Truty R, et al. The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis[J]. Lancet Respir Med, 2022, 10(5): 459-468.
[3] Mullowney T, Manson D, Kim R, et al. Primary ciliary dyskinesia and neonatal respiratory distress[J]. Pediatrics, 2014, 134(6): 1160-1166.
[4] 张静, 白银, 尤少华, 等. Kartagener综合征合并分泌性中耳炎患者的基因诊断[J].中华耳科学杂志, 2014, 12(1): 41-44. ZHANG Jing, BAI Yin, YOU Shaohua, et al. Gene diagnosis in patients with Kartagener syndrome induced chronic secretory otitis media[J]. Chinese Journal of Otology, 2014, 12(1): 41-44.
[5] Rollin M, Seymour K, Hariri M, et al. Rhinosinusitis, symptomatology & absence of polyposis in children with primary ciliary dyskinesia[J]. Rhinology, 2009, 47(1): 75-78.
[6] Lucas JS, Barbato A, Collins SA, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia[J]. Eur Respir J, 2017, 49(1): 1601090.
[7] Shapiro AJ, Davis SD, Polineni D, et al. Diagnosis of primary ciliary dyskinesia. An official American Thoracic Society Clinical Practice Guideline[J]. Am J Respir Crit Care Med, 2018, 197(12): e24-e39.
[8] 中国罕见病联盟呼吸病学分会,原发性纤毛运动障碍诊断与治疗中国共识专家组. 原发性纤毛运动障碍诊断与治疗中国专家共识[J]. 上海医学, 2020, 43(4): 193-202.
[9] 中华医学会儿科学分会呼吸学组疑难少见病协作组,国家呼吸系统疾病临床医学研究中心,《中华实用儿科临床杂志》编辑委员会. 儿童原发性纤毛运动障碍诊断与治疗专家共识[J]. 中华实用儿科临床杂志,2018, 33(2): 94-99.
[10] Wallmeier J, Nielsen KG, Kuehni CE, et al. Motile ciliopathies[J]. Nat Rev Dis Primers, 2020, 6(1): 77.
[11] 王昊, 徐保平. 儿童原发性纤毛运动障碍遗传发病机制与基因诊断研究进展[J].中华实用儿科临床杂志, 2021, 36(10): 786-789. WANG Hao, XU Baoping. Research progress on genetic pathogenesis and gene diagnosis of primary ciliary dyskinesia in children[J]. Chin J Appl Pediatr, 2021, 36(10): 786-789.
[12] 王珂, 陈星, 郭春艳. 等. 原发性纤毛运动障碍三例纤毛结构与基因变异并文献复习[J].中华儿科杂志, 2018, 56(2): 134-137. WANG Ke, CHEN Xing, GUO Chunyan, et al. Cilia ultrastructural and gene variation of primary ciliary dyskinesia: report of three cases and literatures review[J]. Chin J Pediatr, 2018, 56(2): 134-137.
[13] Guo T, Tan ZP, Chen HM, et al. An effective combination of whole-exome sequencing and runs of homozygosity for the diagnosis of primary ciliary dyskinesia in consanguineous families[J]. Sci Rep, 2017, 7(1): 7905.
[14] 李莹, 付文龙, 田代印, 等. 基因检测确诊纤毛结构正常的原发性纤毛运动障碍2例病例报告[J].中国循证儿科杂志, 2020, 15(5): 394-396.
[15] Sui W, Hou X, Che W, et al. CCDC40 mutation as a cause of primary ciliary dyskinesia: a case report and review of literature[J]. Clin Respir J, 2016, 10(5): 614-621.
[16] Liu L, Luo H. Whole-exome sequencing identified a novel compound heterozygous mutation of LRRC6 in a Chinese primary ciliary dyskinesia patient[J]. Biomed Res Int, 2018, 2018: 1854269. doi: 10.1155/2018/1854269.
[17] Li Y, Jiang C, Zhang X, et al. The effect of a novel LRRC6 mutation on the flagellar ultrastructure in a primary ciliary dyskinesia patient[J]. J Assist Reprod Genet, 2021, 38(3): 689-696.
[18] Guan Y, Yang H, Yao X, et al. Clinical and genetic spectrum of children with primary ciliary dyskinesia in China[J]. Chest, 2021, 159(5): 1768-1781.
[19] Liu L, Zhou K, Song Y, et al. CCDC40 mutation as a cause of infertility in a Chinese family with primary ciliary dyskinesia[J]. Medicine, 2021, 100(51): e28275.
[20] Dai HL, Wang D, Guang XF, et al. Pulmonary hypertension in a patient with Kartagener’s syndrome and a novel homozygous nonsense mutation in CCDC40 gene: a case report[J]. Front Med(Lausanne), 2022, 9: 860684. doi: 10.3389/fmed.2022.860684.
[21] Wang L, Zhao X, Liang H, et al. Novel compound heterozygous mutations of DNAH5 identified in a pediatric patient with Kartagener syndrome: case report and literature review[J]. BMC Pulm Med, 2021, 21(1): 263.
[22] Guo Z, Chen W, Wang L, et al. Clinical and genetic spectrum of children with primary ciliary dyskinesia in China[J]. J Pediatr, 2020, 225: 157-165.e5. doi: 10.1016/j.jpeds.2020.05.052.
[23] Xu X, Gong P, Wen J. Clinical and genetic analysis of a family with Kartagener syndrome caused by novel DNAH5 mutations[J]. J Assist Reprod Genet, 2017, 34(2): 275-281.
[24] Kobbernagel HE, Buchvald FF, Haarman EG, et al. Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia(BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial[J]. Lancet Respir Med, 2020, 8(5): 493-505.
[25] Davis SD, Rosenfeld M, Lee HS, et al. Primary ciliary dyskinesia: longitudinal study of lung disease by ultrastructure defect and genotype[J]. Am J Respir Crit Care Med, 2019, 199(2): 190-198.
[26] Frija-Masson J, Bassinet L, Honoré I, et al. Clinical characteristics, functional respiratory decline and follow-up in adult patients with primary ciliary dyskinesia[J]. Thorax, 2017, 72(2): 154-160.
[1] HUANG Xiuli, LIU Bingju, SUN Lifeng. Activated phosphoinositide 3-kinase δ syndrome caused by a mutation in PIK3CD gene: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 107-112.
[2] GONG Yanjie, WANG Long, DONG Laidong, LI Dong, SONG Guangmin, JU Xiuli. Effects of different cryoprotectants and cooling methods on the histology and immunogenicity of heart valves [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 44-49.
[3] QI Qian, WANG Wen, LI Tao, LI Yu. Clinical evaluation of adult patients with bronchiectasis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 68-72.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32 -37 .
[2] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1 -6 .
[3] LONG Tingting, XIE Ming, ZHOU Lu, ZHU Junde. Effect of Noggin protein on learning and memory abilities and the dentate gyrus structure after cerebral ischemia reperfusion injury in mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 15 -23 .
[4] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38 -46 .
[5] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7 -14 .
[6] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24 -31 .
[7] XU Yuxiang, LIU Yudong, ZHANG Peng, DUAN Ruisheng. A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 67 -71 .
[8] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60 -66 .
[9] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
[10] XIAO Juan, XIAO Qiang, CONG Wei, LI Ting, DING Shouluan, ZHANG Yuan, SHAO Chunchun, WU Mei, LIU Jianing, JIA Hongying. Comparison of diagnostic efficacy of two kinds of thyroid imagine reporting and data systems[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 53 -59 .